期刊文献+

CD44v6、MMP-9在脑转移瘤及恶性胶质瘤中的表达及意义

The significane and expression of CD44v6、MMP-9 in brain metastases and malignant glioma invasion.
下载PDF
导出
摘要 目的探讨CD44v6和基质金属蛋白酶MMP-9在脑转移瘤及恶性胶质瘤侵袭行为中的作用。方法应用免疫组织化学S-P法检测CD44v6和MMP-9在良性脑肿瘤、恶性胶质瘤和脑内转移瘤中的表达情况。结果CD44v6在脑内转移瘤中的表达明显高于正常脑组织、良性脑肿瘤组织和恶性胶质瘤组织(P<0.01),后三者CD44v6的表达无明显差异(P>0.05)。MMP-9在恶性脑肿瘤(恶性胶质瘤和脑内转移瘤)中的表达明显高于正常脑组织和良性肿瘤组织(P<0.01),但MMP-9在恶性胶质瘤和脑内转移瘤组织中的表达无明显差异(P>0.05)。结论CD44v6、MMP-9在脑内转移瘤的侵袭、转移中发挥着重要作用。其中CD44v6可作为脑内转移瘤的转移表型,MMP-9则体现脑内转移瘤和恶性胶质瘤的基质降解表型。 Objective To observe the invasive effects of CD44v6 and MMP-9 in the brain metastases and the brain glioma. Methods Determine the expression of CD44v6, MMP -9 in human brain tumors by immunohistorchemistry S-P Methods. Results CD44v6 expressed only in brain metastases . CD44v6 did not express in normal brain tissue,positive brain tumor and glioma . There was obvious difference in statistics analysis . MMP -9 was not obviously showed in normal brain tissues and the positive ratio of MMP- 9 was lower in positive brain tumor tissues, but its positive ratio was higher respectively in glimoa and brain metastases. There was not significant difference at the positive ratio in glioma and brain metastases (P 〉0.05). But they had significant difference to compare with normal brain tissue and positive brain tumors (P〈0.01). Conclusion CD44v6 and MMP- 9 play an important role in the invasive and metastasis procession of malignant tumors . CD44v6 can be used as the metastasic phenotype . MMP -9 can be used as the invasive phenotype.
作者 陈松 王运杰
出处 《现代肿瘤医学》 CAS 2006年第1期9-12,共4页 Journal of Modern Oncology
关键词 脑内转移瘤 CD44V6蛋白 基质金属蛋白酶-9 免疫组织化学 brain metastases CD44v6 matrix mellorproteinase-9 immunohistorchemistry
  • 相关文献

参考文献12

  • 1[1]Giinthert U,Hofmann M,Rudy W,et al.A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cell[J].Cell,1991,65:13.
  • 2[2]Mac Dougal JR,Matrisian LM.Contributions of tumor and stromal matrix metallo - proteinases to tumor progression,invasion and metastasis[J].Cancer Metastasis Rev,1995,14:351 ~362.
  • 3[3]Yamaguchi A,Goi T,Yu J,et al.Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastases and long - term prognosis [J].J Surg Oncol,2002,79 (4):230 ~ 235.
  • 4[4]Gu J,Daa T,Kashima K,et al.Expression of splice variant of CD44 in thyroid neoplasms derived from follicular cells [J].Pathol Int,1998,48(3):184~186.
  • 5[5]Figge J,Gerasing G,Pedov I,et al.Proferential expression of the cell adhesion molecule CD44 in papillary thyroid carcinoma [J].Exp Mol Pathol,1994,61 (3) :203 ~211.
  • 6[6]Li H,Hamou MF,De Tribolet N,et al.Varriant CD44 adhesion molecules are expressed in human brain metastases but not in glioblastmas [J].Cancer Res,1993,53 (22) :5345~5349.
  • 7[7]Li H,Liu J,Hofmann M,et al.Differential CD44 expression patterns in primary brain tumor and brain metastases [J].Br J Cancer,1995,72:160.
  • 8[8]Arch R,Wirth K,Hofmann M,et al.Participation in normal immune response of a metastasis - inducing splicing variant of CD44[J].Science,1992,257:1262.
  • 9李宏,Martin Hofmann,刘佳,江岩,郭丽,罗阳,鲁海欧.CD44v对大鼠多形胶质瘤细胞系RG2的转移促进作用[J].中华肿瘤杂志,1996,18(5):343-346. 被引量:11
  • 10[11]Yamamoto H,Adachi Y,Itch F,et al.Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma [J].Cancer Res,1999,59:3313 ~3316.

二级参考文献5

  • 1李宏,Br J Cancer,1995年,72卷,160页
  • 2李宏,中华肿瘤杂志,1995年,17卷,325页
  • 3李佳,Cell Immunol,1994年,155卷,428页
  • 4李宏,Cancer Res,1993年,53卷,5345页
  • 5李宏,Cancer Lett,1991年,56卷,17页

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部